{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:27:15Z","timestamp":1791289635875,"version":"4.3.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004099","name":"la Ligue Nationale Contre le Cancer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100013501","name":"INCA","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013501","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004431","name":"La Fondation de France","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002915","name":"La Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.molimm.2014.03.013","type":"journal-article","created":{"date-parts":[[2014,4,24]],"date-time":"2014-04-24T07:29:25Z","timestamp":1398324565000},"page":"55-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Molecular basis of mast cell disease"],"prefix":"10.1016","volume":"63","author":[{"given":"Erinn","family":"Soucie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Brenet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Dubreuil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"July (25)","key":"10.1016\/j.molimm.2014.03.013_bib0005","first-page":"1476","article-title":"Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms","volume":"7","author":"Abdel-Wahab","year":"2011","journal-title":"Leukemia"},{"issue":"February (2)","key":"10.1016\/j.molimm.2014.03.013_bib0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrg2932","article-title":"Silencing chromatin: comparing modes and mechanisms","volume":"12","author":"Beisel","year":"2011","journal-title":"Nat. Rev. Genet."},{"issue":"March (3)","key":"10.1016\/j.molimm.2014.03.013_bib0015","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/jid.2009.281","article-title":"Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-kit mutations","volume":"130","author":"Bodemer","year":"2010","journal-title":"J. Invest. Dermatol."},{"issue":"July (30)","key":"10.1016\/j.molimm.2014.03.013_bib0020","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1038\/sj.onc.1206587","article-title":"Signal transduction by several KIT juxtamembrane domain mutations","volume":"22","author":"Casteran","year":"2003","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.molimm.2014.03.013_bib0025","doi-asserted-by":"crossref","first-page":"e85362","DOI":"10.1371\/journal.pone.0085362","article-title":"ASXL1 but not TET2 Mutations Adversely Impact Overall Survival of Patients Suffering Systemic Mastocytosis with Associated Clonal Hematologic Non-Mast-Cell Diseases","volume":"9","author":"Damaj","year":"2014","journal-title":"PLoS ONE"},{"issue":"September (9)","key":"10.1016\/j.molimm.2014.03.013_bib0030","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.molmed.2010.07.002","article-title":"IDH mutations in glioma and acute myeloid leukemia","volume":"16","author":"Dang","year":"2010","journal-title":"Trends Mol. Med."},{"issue":"June (6)","key":"10.1016\/j.molimm.2014.03.013_bib0035","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.tibs.2012.02.002","article-title":"Design principles of interconnections between chromatin and pre-mRNA splicing","volume":"37","author":"de Almeida","year":"2012","journal-title":"Trends Biochem. Sci."},{"issue":"September (9)","key":"10.1016\/j.molimm.2014.03.013_bib0040","doi-asserted-by":"crossref","first-page":"R99","DOI":"10.1186\/gb-2013-14-9-r99","article-title":"PU.1 target genes undergo tet2-coupled demethylation and dnmt3b-mediated methylation in monocyte-to-osteoclast differentiation","volume":"14","author":"de la Rica","year":"2013","journal-title":"Genome Biol."},{"issue":"January (1)","key":"10.1016\/j.molimm.2014.03.013_bib0045","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3324\/haematol.11558","article-title":"Biochemical markers predictive for bone marrow involvement in systemic mastocytosis","volume":"93","author":"Donker","year":"2008","journal-title":"Haematologica"},{"issue":"September (3)","key":"10.1016\/j.molimm.2014.03.013_bib0050","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s12032-011-0074-y","article-title":"Frequencies of KIT and PDGFRA mutations in the molecgist prospective population-based study differ from those of advanced gists","volume":"29","author":"Emile","year":"2012","journal-title":"Med. Oncol."},{"issue":"December (6)","key":"10.1016\/j.molimm.2014.03.013_bib0055","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ccr.2010.11.015","article-title":"Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation","volume":"18","author":"Figueroa","year":"2010","journal-title":"Cancer Cell"},{"issue":"October (4)","key":"10.1016\/j.molimm.2014.03.013_bib0060","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1172\/JCI116761","article-title":"Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product","volume":"92","author":"Furitsu","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2014.03.013_bib0065","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1756-8722-5-12","article-title":"Birnbaum D Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases","volume":"5","author":"Gelsi-Boyer","year":"2012","journal-title":"J. Hematol. Oncol."},{"issue":"July (1)","key":"10.1016\/j.molimm.2014.03.013_bib0070","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-0609.2012.01761.x","article-title":"Mast cell leukemia: Identification of a new c-kit mutation, dup(501\u2013502), and response to masitinib, a c-kit tyrosine kinase inhibitor","volume":"89","author":"Georgin-Lavialle","year":"2012","journal-title":"Eur. J. Haematol."},{"issue":"February (8)","key":"10.1016\/j.molimm.2014.03.013_bib0075","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1182\/blood-2012-07-442400","article-title":"Mast cell leukemia","volume":"121","author":"Georgin-Lavialle","year":"2013","journal-title":"Blood"},{"issue":"February (6)","key":"10.1016\/j.molimm.2014.03.013_bib0080","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1200\/JCO.2012.41.9549","article-title":"Mast cell sarcoma: a rare and aggressive entity \u2013 report of two cases and review of the literature","volume":"31","author":"Georgin-Lavialle","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"February (6)","key":"10.1016\/j.molimm.2014.03.013_bib0085","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1182\/blood-2008-11-189605","article-title":"Mast cell hyperplasia, b-cell malignancy, and intestinal inflammation in mice with conditional expression of a constitutively active kit","volume":"117","author":"Gerbaulet","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2014.03.013_bib0090","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2013.095133","article-title":"SRSF2-P95 Hotspot Mutation is Highly Associated with Aggressive Forms of Mastocytosis and Mutations in Epigenetic Regulator Genes","author":"Hanssens","year":"2014","journal-title":"Haematologica"},{"issue":"October (1)","key":"10.1016\/j.molimm.2014.03.013_bib0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molcel.2011.08.026","article-title":"Directional DNA methylation changes and complex intermediate states accompany lineage specificity in the adult hematopoietic compartment","volume":"44","author":"Hodges","year":"2011","journal-title":"Mol. Cell"},{"issue":"October (19)","key":"10.1016\/j.molimm.2014.03.013_bib0100","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1158\/0008-5472.CAN-12-4306","article-title":"The cpg island methylator phenotype: what's in a name?","volume":"73","author":"Hughes","year":"2013","journal-title":"Cancer Res."},{"issue":"May (4)","key":"10.1016\/j.molimm.2014.03.013_bib0105","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.cell.2013.04.028","article-title":"SR proteins collaborate with 7SK and promoter-associated nascent RNA to release paused polymerase","volume":"153","author":"Ji","year":"2013","journal-title":"Cell"},{"issue":"June (6)","key":"10.1016\/j.molimm.2014.03.013_bib0110","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/leu.2013.80","article-title":"Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies","volume":"27","author":"Khan","year":"2013","journal-title":"Leukemia"},{"issue":"March (3)","key":"10.1016\/j.molimm.2014.03.013_bib0115","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/PAS.0b013e31828446d6","article-title":"Pediatric mast cell sarcoma of temporal bone with novel L799F (2395C>T) KIT mutation, mimicking histiocytic neoplasm","volume":"37","author":"Kim","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"issue":"December (7325)","key":"10.1016\/j.molimm.2014.03.013_bib0120","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nature09586","article-title":"Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2","volume":"468","author":"Ko","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2014.03.013_bib0125","first-page":"13","article-title":"The human mast cell: an overview","volume":"315","author":"Krishnaswamy","year":"2006","journal-title":"Methods Mol. Biol."},{"issue":"July (7)","key":"10.1016\/j.molimm.2014.03.013_bib0130","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ng.391","article-title":"Acquired mutations in TET2 are common in myelodysplastic syndromes","volume":"41","author":"Langemeijer","year":"2009","journal-title":"Nat. Genet."},{"issue":"May (2)","key":"10.1016\/j.molimm.2014.03.013_bib0135","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/j.semdp.2006.08.006","article-title":"KIT and PDGFRA mutations in gastrointestinal stromal tumors (gists)","volume":"23","author":"Lasota","year":"2006","journal-title":"Semin. Diagn. Pathol."},{"issue":"January (1)","key":"10.1016\/j.molimm.2014.03.013_bib0140","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1074\/jbc.M109.065862","article-title":"ASXL1 represses retinoic acid receptor-mediated transcription through associating with HP1 and LSD1","volume":"285","author":"Lee","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"June (23)","key":"10.1016\/j.molimm.2014.03.013_bib0145","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1182\/blood-2009-02-205237","article-title":"Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors","volume":"113","author":"Lim","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2014.03.013_bib0150","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-0-387-77374-2_7","article-title":"SR proteins and related factors in alternative splicing","volume":"623","author":"Lin","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"issue":"August (8)","key":"10.1016\/j.molimm.2014.03.013_bib0155","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nsmb.1461","article-title":"The splicing factor SC35 has an active role in transcriptional elongation","volume":"15","author":"Lin","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"March (7390)","key":"10.1016\/j.molimm.2014.03.013_bib0160","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nature10860","article-title":"IDH mutation impairs histone demethylation and results in a block to cell differentiation","volume":"483","author":"Lu","year":"2012","journal-title":"Nature"},{"issue":"January (1)","key":"10.1016\/j.molimm.2014.03.013_bib0165","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cell.2010.11.056","article-title":"Epigenetics in alternative pre-mRNA splicing","volume":"144","author":"Luco","year":"2011","journal-title":"Cell"},{"issue":"March (5)","key":"10.1016\/j.molimm.2014.03.013_bib0170","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1182\/blood.V99.5.1741","article-title":"The c-kit mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations","volume":"99","author":"Ma","year":"2002","journal-title":"Blood"},{"issue":"August (7205)","key":"10.1016\/j.molimm.2014.03.013_bib0175","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nature07107","article-title":"Genome-scale DNA methylation maps of pluripotent and differentiated cells","volume":"454","author":"Meissner","year":"2008","journal-title":"Nature"},{"issue":"July (1)","key":"10.1016\/j.molimm.2014.03.013_bib0180","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2011.06.001","article-title":"TET2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation","volume":"20","author":"Moran-Crusio","year":"2011","journal-title":"Cancer Cell"},{"issue":"April (4)","key":"10.1016\/j.molimm.2014.03.013_bib0185","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/ajh.23459","article-title":"Systemic mastocytosis in adults: 2012 update on diagnosis, risk stratification, and management","volume":"87","author":"Pardanani","year":"2012","journal-title":"Am. J. Hematol."},{"issue":"June (7299)","key":"10.1016\/j.molimm.2014.03.013_bib0190","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nature09230","article-title":"Epigenetics as a unifying principle in the aetiology of complex traits and diseases","volume":"465","author":"Petronis","year":"2010","journal-title":"Nature"},{"issue":"July (1)","key":"10.1016\/j.molimm.2014.03.013_bib0195","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccr.2011.06.003","article-title":"TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis","volume":"20","author":"Quivoron","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molimm.2014.03.013_bib0200","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3389\/fonc.2013.00169","article-title":"The emerging role of d-2-hydroxyglutarate as an oncometabolite in hematolymphoid and central nervous system neoplasms","volume":"3","author":"Rakheja","year":"2013","journal-title":"Front. Oncol."},{"issue":"July (13)","key":"10.1016\/j.molimm.2014.03.013_bib0205","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/jnci\/djq187","article-title":"Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism","volume":"102","author":"Reitman","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"issue":"September (9)","key":"10.1016\/j.molimm.2014.03.013_bib0210","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/modpathol.2011.84","article-title":"Evaluation of the WHO criteria for the classification of patients with mastocytosis","volume":"24","author":"S\u00e1nchez-Mu\u00f1oz","year":"2011","journal-title":"Mod. Pathol."},{"issue":"May (7295)","key":"10.1016\/j.molimm.2014.03.013_bib0215","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nature08966","article-title":"Histone H2A deubiquitinase activity of the polycomb repressive complex PR-DUB","volume":"465","author":"Scheuermann","year":"2010","journal-title":"Nature"},{"issue":"October (14)","key":"10.1016\/j.molimm.2014.03.013_bib0220","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1182\/blood-2013-04-496448","article-title":"Comprehensive mutational profiling in advanced systemic mastocytosis","volume":"122","author":"Schwaab","year":"2013","journal-title":"Blood"},{"issue":"September (9)","key":"10.1016\/j.molimm.2014.03.013_bib0225","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrc3343","article-title":"The role of mutations in epigenetic regulators in myeloid malignancies","volume":"12","author":"Shih","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"December (24)","key":"10.1016\/j.molimm.2014.03.013_bib0230","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1182\/blood-2011-12-397588","article-title":"In aggressive forms of mastocytosis. TET2 loss cooperates with c-KITD816V to transform mast cells","volume":"120","author":"Soucie","year":"2012","journal-title":"Blood"},{"issue":"June (3)","key":"10.1016\/j.molimm.2014.03.013_bib0235","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1586\/ehm.12.12","article-title":"Diagnosis, progression patterns and prognostication in mastocytosis","volume":"5","author":"Sperr","year":"2012","journal-title":"Expert Rev Hematol"},{"issue":"6","key":"10.1016\/j.molimm.2014.03.013_bib0240","doi-asserted-by":"crossref","first-page":"R54","DOI":"10.1186\/gb-2011-12-6-r54","article-title":"5-Hydroxymethylcytosine is associated with enhancers and gene bodies in human embryonic stem cells","volume":"12","author":"Stroud","year":"2011","journal-title":"Genome Biol."},{"issue":"June (11)","key":"10.1016\/j.molimm.2014.03.013_bib0245","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1242\/dev.070771","article-title":"Tet family proteins and 5-hydroxymethylcytosine in development and disease","volume":"139","author":"Tan","year":"2012","journal-title":"Development"},{"issue":"March (3)","key":"10.1016\/j.molimm.2014.03.013_bib0250","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0167-5699(94)90153-8","article-title":"The riddle of the mast cell: kit(CD117)-ligand as the missing link?","volume":"15","author":"Valent","year":"1994","journal-title":"Immunol. Today"},{"issue":"July (7)","key":"10.1016\/j.molimm.2014.03.013_bib0255","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk. Res."},{"issue":"December (12)","key":"10.1016\/j.molimm.2014.03.013_bib0260","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1038\/leu.2012.130","article-title":"Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders","volume":"26","author":"Visconte","year":"2012","journal-title":"Leukemia"},{"issue":"March (3)","key":"10.1016\/j.molimm.2014.03.013_bib0265","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ajh.23380","article-title":"Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: clinical significance and comparison of chomosomal abnormalities in SM and AHNMD components","volume":"88","author":"Wang","year":"2013","journal-title":"Am. J. Hematol."},{"issue":"March (3)","key":"10.1016\/j.molimm.2014.03.013_bib0270","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ccr.2010.01.020","article-title":"The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate","volume":"17","author":"Ward","year":"2010","journal-title":"Cancer Cell"},{"issue":"May (4)","key":"10.1016\/j.molimm.2014.03.013_bib0275","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.molcel.2011.04.005","article-title":"Genome-wide regulation of 5hmc, 5mc, and gene expression by tet1 hydroxylase in mouse embryonic stem cells","volume":"42","author":"Xu","year":"2011","journal-title":"Mol. Cell"},{"issue":"August (7)","key":"10.1016\/j.molimm.2014.03.013_bib0280","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1182\/blood-2009-06-226027","article-title":"Pediatric mastocytosis-associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with kit-phosphotransferase domain mutations","volume":"116","author":"Yang","year":"2010","journal-title":"Blood"},{"issue":"December (12)","key":"10.1016\/j.molimm.2014.03.013_bib0285","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1084\/jem.20050807","article-title":"Mastocytosis in mice expressing human kit receptor with the activating asp816val mutation","volume":"202","author":"Zappulla","year":"2005","journal-title":"J. Exp. Med."},{"issue":"February (5)","key":"10.1016\/j.molimm.2014.03.013_bib0290","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/sj.onc.1206120","article-title":"Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasms","volume":"22","author":"Zermati","year":"2003","journal-title":"Oncogene"},{"issue":"July (1)","key":"10.1016\/j.molimm.2014.03.013_bib0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molcel.2009.06.016","article-title":"SR proteins in vertical integration of gene expression from transcription to RNA processing to translation","volume":"35","author":"Zhong","year":"2009","journal-title":"Mol. Cell"}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589014000753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589014000753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T05:08:45Z","timestamp":1716700125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589014000753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0161589014000753"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2014.03.013","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular basis of mast cell disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2014.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}